Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast: Erratum : International Journal of Women's Dermatology

Secondary Logo

Journal Logo

Erratum

Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast: Erratum

Author Information
International Journal of Women’s Dermatology: October 2022 - Volume 8 - Issue 3 - p e052
doi: 10.1097/JW9.0000000000000052
  • Open

In the article entitled “Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast” (International Journal of Women’s Dermatology, June 2022, Volume 8, Issue 2), by Belzer et al., the correct answers to the questions were missing and have been provided below.

What is your diagnosis?

  1. Chronic radiation dermatitis
  2. Inflammatory breast cancer
  3. Cellulitis
  4. Carcinoma en cuirasse
  5. Radiation-induced morphea (RIM)/LS overlap

Correct answer: 5. Radiation-induced morphea (RIM)/LS overlap.

Which of the following statements regarding RIM is true?

  • A. RIM typically develops during RT
  • B. RIM is dependent on radiation dose
  • C. RIM may extend beyond the radiation field
  • D. RIM is a precursor to angiosarcoma
  • E. RIM typically demonstrates atypical fibroblasts and vascular
  • ectasia on pathology

Correct answer: C. RIM may extend beyond the radiation field.

Which of the following diagnostic tests is recommended when evaluating for potential RIM in a woman with a history of breast cancer?

  • A. Ultrasound of the breast
  • B. Punch biopsy of affected skin
  • C. Serum anti-nuclear antibody
  • D. Serum anti-scleroderma-70 (topoisomerase 1) antibody
  • E. No diagnostic tests indicated

Correct answer: B. Punch biopsy of affected skin.

Reference

1. Belzer A, McNiff JM, Leventhal JS. Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast. Int J Women’s Dermatol 2022;8:e016.
Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of Women’s Dermatologic Society.